Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter(CeMM Research Center for Molecular Medicine), James E. Bradner(Novartis (China)), Sirano Dhe‐Paganon(University of Toronto), Dennis L. Buckley(Novartis (United States)), Amanda Souza(Dana-Farber Cancer Institute), Justin M. Roberts(Dana-Farber Cancer Institute), Joshiawa Paulk(Novartis (United States))
Cited by 1,713
Related Papers
Crystal Structure of the Tyrosine Phosphatase SHP-2
|Cell|1998|1k
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
|Nature Medicine|2014|664
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
|Nature|2016|629
Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1
|Nature|2008|469
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
|Nature Cell Biology|2018|435